Differential Class III Antiarrhythmic Effects of Ambasilide and Dofetilide at Different Extracellular Potassium and Pacing Frequencies
- 1 August 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 28 (2) , 314-320
- https://doi.org/10.1097/00005344-199608000-00019
Abstract
Summary We studied the effect of two new class III antiarrhythmics, ambasilide and dofetilide, on the action potential duration (APD) of guinea pig right ventricular papillary muscle at different extracellular potassium concentrations ([K+e]) and pacing frequencies. Under normal [K+e], both drugs significantly prolonged APD90 (APD at 90% repolarization) at 0.5 Hz. The effect of ambasilide was well preserved at rapid pacing rates, independent of [K+e]. The effect of dofetilide was markedly reduced with increasing pacing rate, especially in high [K+e]. Therefore, ambasilide may be useful in treating tachyarrhythmias in normal, as well as in altered [K+e] conditions.Keywords
This publication has 35 references indexed in Scilit:
- Modulation of procainamide's effect on cardiac conduction in dogs by extracellular potassium concentration. A quantitative analysis.Circulation, 1994
- Heterogeneity in extracellular potassium concentration during early myocardial ischaemia and reperfusion: implications for arrhythmogenesisCardiovascular Research, 1994
- New class III antiarrhythmic drugsEuropean Heart Journal, 1993
- Frequency-dependent electrophysiologic effects of amiodarone in humans.Circulation, 1993
- Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide.Circulation Research, 1993
- Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricleThe American Journal of Cardiology, 1991
- Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.Circulation, 1990
- Mortality in heart failure: clinical variables of prognostic value.Heart, 1987
- Amiodarone and hypokalemia. A dangerous combinationInternational Journal of Cardiology, 1986
- Interaction of the effects of hypoxia, substrate depletion, acidosis and hyperkalaemia on the class III antiarrhythmic properties of sotalolCardiovascular Research, 1985